Autobio Diagnostics Co., Ltd.

603658

CNE100002GC4

Medical Equipment, Supplies & Distribution

End-of-day quote Shanghai S.E. Other stock markets 2025-01-20			5-day change	1st Jan Change
40.41 ^CNY	+0.72%		+1.00%	-7.40%

01-02	Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.	CI
12-26	Autobio Diagnostics Registers Several Medical Devices With National, Provincial Regulators	MT

Autobio Diagnostics' Chairman Raises Stake in Company for 21 Million Yuan

December 13, 2024 at 01:34 am

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Autobio Diagnostics Co., Ltd.

Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.	01-02	CI
Autobio Diagnostics Registers Several Medical Devices With National, Provincial Regulators	12-26	MT
Autobio Diagnostics' Chairman Raises Stake in Company for 21 Million Yuan	12-13	MT
Autobio Diagnostics Gets Registration Certificates for Five Medical Devices	11-25	MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	24-10-25	CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.	24-10-08	CI
Autobio Diagnostics H1 Profit Up 13%, Operating Income Rises 5%	24-08-20	MT
Autobio Diagnostics Gets Registration Certificates for Four Devices; Shares Up 3%	24-08-15	MT
Autobio Diagnostics Gets Registration Certificates for 14 Devices	24-07-02	MT
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.	24-07-01	CI
Autobio Diagnostics' Unit Gets Nod for Two Products	24-05-21	MT
Autobio Diagnostics' Q1 Profit Jumps 34%	24-04-18	MT
Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat	24-04-18	MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	24-04-18	CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.	24-04-01	CI
Autobio Diagnostics Secures Registration Certificates for 11 Devices	24-04-01	MT
Autobio Diagnostics Gets Regulatory Nod in China for 16 Devices	24-02-23	MT
Autobio Diagnostics Co., Ltd. commences an Equity Buyback Plan for CNY 500 million worth of its shares, under the authorization approved on February 20, 2024.	24-02-20	CI
Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan.	24-01-28	CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to S&P Global BMI Index	23-09-18	CI
Autobio Diagnostics Logs Low Single-Digit Earnings Growth in H1	23-08-18	MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-17	CI
Autobio Diagnostics Gets Registration Certificates for Five Devices	23-05-24	MT
Shenzhen Meili Namikong Technology Co., Ltd. announced that it has received funding from Autobio Diagnostics Co., Ltd.	23-04-25	CI

Chart Autobio Diagnostics Co., Ltd.

Duration

Period

603658: Dynamic Chart

Autobio Diagnostics Co., Ltd. is a China-based company and mainly engaged in development, manufacture and sales of diagnostics products. The Company's main products include gnostic products, microbiology detection products, and related devices. The immunodiagnostic products include microplate chemiluminescence diagnostic reagents, Enzyme-Linked immunosorbent assay diagnostic reagents, magnetic particle chemiluminescence detection reagents, and colloidal diagnostic reagents. The microbiology detection products include training detection reagents, susceptibility detection reagents and rapid detection reagents. The device products include microplate readers, chemiluminescence immunoassay analyzers, and united testing analyzers. The Company distributes its products in domestic markets.

Employees

5,539

Sector

Medical Equipment, Supplies & Distribution

Calendar

2025-04-17 - Q1 2025 Earnings Release (Projected)

More about the company